Baby Rabbit Complement Serum

Referência OOSA10422

Tamanho : 2ml

Marca : Aviva Systems Biology

Solicitar mais informações

Contactar o distribuidor local :


Telefone : +1 850 650 7790

Baby Rabbit Complement Serum (OOSA10422)

Datasheets/ManualsPrintable datasheet for Baby Rabbit Complement Serum (OOSA10422)
Product Info
Predicted Species ReactivityRabbit
Product FormatLyophilized
ApplicationFC
Additional InformationThis product is not sold as sterile but can be sterilized by filtration if necessary. It is preferable to dilute the complement to a final working concentration before filtration in order to minimize loss of volume.
Reconstitution and Storage2°C to 8°C|-80°C
Reference1. Council of Europe. (1983) Essential aspects of tissue typing: Preparation, use, storage of reagents and standardisation of complement. European Health Committee, Strasbourg, ISBN 92-871.224-4.
2. Edited by J.G.Ray. (1979) NIAID Manual of tissue typing techniques . Publication No. NIH-80-545.
3. Anderson. L.D. Jr, et al. (1999) Enhancement of graft-versus-tumor activity and graft-versus-host disease by pretransplant immunization of allogenic bone marrow donors with a recipient-derived tumor cell vaccine. Cancer Res. 59: 1525-1530.
4. Mason. J. et al. (2002) Statin-induced expression of decay-accelerating factor protects vascular endothelium against complement-mediated injury. Circ.Res. 91: 969-703.
5. Lidington. E. et al. (2000) Induction of decay-accelerating factor by thrombin through a protease-activated receptor 1 and protein kinase C-dependent pathway protects vascular endothelial cells from complement mediated injury. Blood. 96: 2784-2972.
6. De Clerq. L. et al. (1997) An anti-adipocyte monoclonal antibody is cytotoxic to porcine preadipocytes in vitro and depresses the development of pig adipose tissue. J.Anim. Sci. 75: 1791-1797.
Description of TargetBaby Rabbit Complement Serum